Pediatric OSAS treatment is shifting towards a tailored, multidisciplinary approach, moving beyond a one-size-fits-all model. Adenotonsillectomy is the standard first-line treatment, improving sleep ...

Credit: Getty Images The ATS guideline covers CPAP use, orthodontic treatment, weight loss intervention, lingual tonsillar hypertrophy, supraglottoplasty, and montelukast use. The American Thoracic ...

Sleep apnea not only can affect the growth and development of children, but it also can affect their health as adults. Early recognition is important to prevent long-term consequences. Though loud ...

LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (VVOS), a leading medical device and technology company specializing in the development and commercialization of highly ...

Vitamin D deficiency is common in children with severe obstructive sleep apnea (OSA) and is associated with increased OSA severity. Lower serum 25-hydroxyvitamin D levels correlate with higher ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an obstructive sleep apnea neurostimulation therapy for patients aged 13 years and older with ...

In a multivariable analysis of kids who were undergoing adenotonsillectomy, obstructive Apnea-Hypopnea Index (AHI) scores (which range from ≥5 to ≥30 apnea and hypopnea events per hour) were ...

The clinical syndrome of obstructive sleep apnea (OSAS) in children is a distinct, yet somewhat overlapping disorder with the condition that occurs in adults, such that the clinical manifestations, ...

On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, which is used to treat moderate to severe obstructive sleep apnea (OSA) and ...

OSA affects about 1 in 5 adults and increases the risk of heart disease and diabetes. Home sleep apnea tests (HSAT) offer accessible and cost-effective diagnosis. CPAP remains the gold standard, but ...